Profusa, Inc. (PFSA) Cash Flow Statement

NASDAQ: PFSAOperating cash, capex, free cash flow and buybacks.

Where PFSA’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$16.2M
Capital expenditures
$8,000
Free cash flow
−$16.3M
Returned to shareholders
—
Change in cash
$1.6M
cash at year-end $1.8M
Borrowing: $9.6MBorrowing$9.6MOther financing: $10.3MOther financing$10.3MCash used in operations: $16.2MCash used in operations$16.2M · 82%Investments (net): $2.0MInvestments (net)$2.0M · 10%Added to cash: $1.6MAdded to cash$1.6M · 8%Capital expenditures: $8,000Capital expenditures$8,000 · 0%$19.8M
Cash from operations
−$16.2M
Investments (net)
−$2.0M
Net borrowing (repayment)
+$9.6M
Other financing
+$10.3M
Change in cash
$1.6M

Drawn to scale: where the cash came from and how it was used. Hover for values.

PFSA operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

PFSA cash flow trends, 2021–2025

Profusa, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$10.7M2021−$16.2M2025—
Capital expenditures$02021$8,0002025—
Free cash flow−$10.7M2021−$16.3M2025—
Stock-based compensation$72,0002021$891,0002025+87.6%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

PFSA cash flow by activity

OperatingInvestingFinancingChange in cash

PFSA net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

PFSA cash flow statement

Profusa, Inc. annual cash flow statement
20252024202320222021
Operating activities
Net income−$35.8M−$9.2M−$10.3M−$20.2M−$10.3M
Depreciation & amortization———$724,000$1.2M
Stock-based compensation$891,000$21,000$33,000$111,000$72,000
Change in working capital$4.3M$2.4M$1.5M$909,000−$522,000
Other non-cash items$14.3M$4.7M$4.3M$10.8M−$1.1M
Cash from operating activities−$16.2M−$2.1M−$4.4M−$7.7M−$10.7M
Investing activities
Capital expenditures−$8,000$0−$2,000$0$0
Investments (net)−$2.0M$0−$2,000——
Acquisitions & other investing$0—$2,000——
Cash from investing activities−$2.0M—−$2,000——
Financing activities
Net borrowing (repayment)$9.6M$3.1M$5.1M$7.7M$8.7M
Shares issued$0$0$0$0$0
Other financing$10.3M−$961,000−$591,000−$772,000$51,000
Cash from financing activities$19.8M$2.1M$4.5M$6.9M$8.8M
Summary
Net change in cash$1.6M$49,000$64,000−$778,000−$1.9M
Cash at end of period$1.8M$191,000$142,000$78,000$856,000
Free cash flow−$16.3M−$2.1M−$4.4M−$7.7M−$10.7M

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

PFSA cash generation

In fiscal 2025 (ended December 31, 2025), Profusa generated -$16.2 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of -$16.3 million. Cash and equivalents rose by $1.6 million over the year.

Related: PFSA income statement, PFSA balance sheet. See the PFSA stock overview for the latest quote and news.

PFSA cash flow FAQ

What is Profusa's free cash flow?

Profusa's free cash flow was -$16.3 million in fiscal 2025: -$16.2 million of operating cash flow minus $0.0 million of capital expenditures It was -$2.1 million a year earlier..

How much cash does Profusa generate from operations?

Profusa generated -$16.2 million of cash from operating activities in fiscal 2025.

How much does Profusa spend on capital expenditures?

Profusa spent $0.0 million on capital expenditures in fiscal 2025.

Medical Devices: cash flow